84 filings
8-K
ADMS
Adamas Pharmaceuticals Inc
24 Nov 21
Completion of Acquisition or Disposition of Assets
9:18am
8-K
ADMS
Adamas Pharmaceuticals Inc
12 Oct 21
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
6:59am
8-K
ADMS
Adamas Pharmaceuticals Inc
9 Aug 21
Adamas reports second quarter 2021 financial results
4:04pm
8-K
ADMS
Adamas Pharmaceuticals Inc
11 Jun 21
Departure of Directors or Certain Officers
4:00pm
8-K
ADMS
Adamas Pharmaceuticals Inc
4 Jun 21
Submission of Matters to a Vote of Security Holders
4:02pm
8-K
glyoitegclc9x682a
10 May 21
Adamas reports first quarter 2021 financial results
4:04pm
8-K
6ni2x1d 7nkkpau3
25 Feb 21
Other Events
4:15pm
8-K
cs4ufdoi3etzc
23 Feb 21
Adamas Reports Fourth Quarter and Full Year 2020 Financial Results
4:05pm
8-K
zpbkgptg
1 Feb 21
Entry into a Material Definitive Agreement
8:05am
8-K
tgxbl15f1 uzvmurzwq
13 Jan 21
Adamas Provides Preliminary Fourth Quarter and Full Year 2020 Total Revenues and Key Business Drivers for 2021
9:27am
8-K
7ppssdwg 1nr8uc5ob
2 Dec 20
Entry into a Material Definitive Agreement
6:59am
8-K
x9d2ihk 117
23 Nov 20
Departure of Directors or Certain Officers
9:20am
8-K
raxpdc0a
5 Nov 20
Adamas Reports Third Quarter 2020 Financial Results
4:08pm
8-K
mx45qmt7o2usem
1 Sep 20
Departure of Directors or Certain Officers
9:19am
8-K
tqlnampnuix ok3n
6 Aug 20
Adamas Reports Second Quarter 2020 Financial Results
4:04pm
8-K
0zue7
17 Jun 20
Other Events
4:03pm
8-K
yvlgmjh3n7qrwp
5 Jun 20
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
34linepc 3le
4 Jun 20
Other Events
4:32pm
8-K
zg9m27n65h6vy4a ey0
7 May 20
Adamas Reports First Quarter 2020 Financial Results
4:07pm
8-K
t4wvxpe
25 Feb 20
Adamas Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm